NCI Selects Two Assays for the Vanguard Study on Multi-Cancer Detection Tests POSTED: January 7, 2025SOURCE: DCP News The National Cancer Institute (NCI) has selected two assays to be included in the Vanguard Study: Avantect® Multi-Cancer Detection Test by ClearNote Health and Shield™ Multi-Cancer Detection Test by Guardant Health. Date Posted All 2032 2031 2030 2029 2028 2027 2026 2025 2024 2023 2022 2021 2020 2019 No matching News Articles were found.